Vericel Company Presentation - JPMorgan Healthcare Conference January 15 2025.pdf

1、Advanced Therapies for the Sports Medicine&Severe Burn Care Markets43RDANNUAL J.P.MORGAN HEALTHCARE CONFERENCEJANUARY 15,2025Forward-Looking Statements2Vericel cautions you that all statements other than statements ofhistorical fact included in this presentation that address activities,events or dev

2、elopments that we expect,believe or anticipate willor may occur in the future are forward-looking statements.Although we believe that we have a reasonable basis for theforward-looking statements contained herein,they are based oncurrent expectations about future events affecting us and aresubject to

3、 risks,assumptions,uncertainties and factors relating toour operations and business environment,all of which are difficultto predict and many of which are beyond our control.Our actualresults may differ materially from those expressed or implied bythe forward-looking statements in this presentation.

4、Thesestatements are often,but are not always,made through the useof words or phrases such as“anticipates,”“intends,”“estimates,”“plans,”“expects,”“continues,”“believe,”“guidance,”“outlook,”“target,”“future,”“potential,”“goals”and similar words orphrases,or future or conditional verbs such as“will,”“

5、would,”“should,”“could,”“may,”or similarexpressions.Among the factors that could cause actual results to differmaterially from those set forth in the forward-looking statementsinclude,but are not limited to,the inherent uncertaintiesassociated with our expectations concerning revenue results forthe

6、fourth quarter and full-year ended 2024,gross margin,netincome,adjusted EBITDA,and estimates of our cash,restrictedcash and investments as of December 31,2024.Vericels revenueexpectations for the fourth quarter and full-year ended 2024,aswell as its estimates concerning gross margin,net income,adjus